Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,030 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Monitoring tryptophan metabolism in chronic immune activation.
Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D. Schröcksnadel K, et al. Clin Chim Acta. 2006 Feb;364(1-2):82-90. doi: 10.1016/j.cca.2005.06.013. Epub 2005 Sep 1. Clin Chim Acta. 2006. PMID: 16139256 Review.
Parameters of soluble immune activation in vivo correlate negatively with the proliferative capacity of peripheral blood mononuclear cells in vitro in HIV-infected patients.
Schroecksnadel K, Winkler C, Sarcletti M, Romani N, Banki Z, Ebner S, Fuchs D, Zangerle R. Schroecksnadel K, et al. J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):354-9. doi: 10.1097/QAI.0b013e318198a6e1. J Acquir Immune Defic Syndr. 2009. PMID: 19214125
CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2,3-dioxygenase.
Pree I, Bigenzahn S, Fuchs D, Koporc Z, Nierlich P, Winkler C, Brandacher G, Sykes M, Muehlbacher F, Langer F, Wekerle T. Pree I, et al. Transplantation. 2007 Mar 15;83(5):663-7. doi: 10.1097/01.tp.0000255594.23445.29. Transplantation. 2007. PMID: 17353791 Free PMC article.
Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.
Hainz U, Obexer P, Winkler C, Sedlmayr P, Takikawa O, Greinix H, Lawitschka A, Pötschger U, Fuchs D, Ladisch S, Heitger A. Hainz U, et al. Blood. 2005 May 15;105(10):4127-34. doi: 10.1182/blood-2004-05-1726. Epub 2005 Jan 27. Blood. 2005. PMID: 15677560 Free PMC article.
Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients.
Schroecksnadel K, Winkler C, Werner ER, Sarcletti M, Romani N, Ebner S, Schennach H, Fuchs D, Zangerle R. Schroecksnadel K, et al. Biol Chem. 2009 Feb;390(2):115-23. doi: 10.1515/BC.2009.018. Biol Chem. 2009. PMID: 19040353
Hyperhomocysteinaemia and immune activation in patients with cancer.
Schroecksnadel K, Frick B, Fiegl M, Winkler C, Denz HA, Fuchs D. Schroecksnadel K, et al. Clin Chem Lab Med. 2007;45(1):47-53. doi: 10.1515/CCLM.2007.012. Clin Chem Lab Med. 2007. PMID: 17243914
Most patients were found to have elevated concentrations of the immune activation and inflammation markers neopterin and C-reactive protein (CRP), as well as a higher erythrocyte sedimentation rate (ESR). ...
Most patients were found to have elevated concentrations of the immune activation and inflammation markers neopterin and C-reactive p …
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Göbel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A. Brandacher G, et al. Clin Cancer Res. 2006 Feb 15;12(4):1144-51. doi: 10.1158/1078-0432.CCR-05-1966. Clin Cancer Res. 2006. PMID: 16489067
Non-peptidic delta-opioid receptor antagonists suppress mitogen-induced tryptophan degradation in peripheral blood mononuclear cells in vitro.
Jenny M, Winkler C, Spetea M, Schennach H, Schmidhammer H, Fuchs D. Jenny M, et al. Immunol Lett. 2008 Jun 15;118(1):82-7. doi: 10.1016/j.imlet.2008.03.006. Epub 2008 Apr 10. Immunol Lett. 2008. PMID: 18440650
Diminished quality of life in patients with cancer correlates with tryptophan degradation.
Schroecksnadel K, Fiegl M, Prassl K, Winkler C, Denz HA, Fuchs D. Schroecksnadel K, et al. J Cancer Res Clin Oncol. 2007 Jul;133(7):477-85. doi: 10.1007/s00432-007-0191-3. Epub 2007 Mar 14. J Cancer Res Clin Oncol. 2007. PMID: 17356858
1,030 results
Jump to page
Feedback